Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
27,615,000
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
6,122,432
-
Shares change
-
+86,711
-
Total reported value, excl. options
-
$33,793,000
-
Value change
-
+$406,933
-
Number of buys
-
6
-
Number of sells
-
-6
-
Price
-
$5.51
Significant Holders of BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) as of Q2 2020
16 filings reported holding PHGE - BiomX Inc. - Common stock, par value $0.0001 per share as of Q2 2020.
BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,122,432 shares
of 27,615,000 outstanding shares and own 22% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2,313,489 shares), Johnson & Johnson Innovation - JJDC, Inc. (2,133,402 shares), MMCAP International Inc. SPC (684,451 shares), RTW INVESTMENTS, LP (600,000 shares), MILLENNIUM MANAGEMENT LLC (295,615 shares), Taylor Wealth Management Partners (43,552 shares), LMR Partners LLP (29,039 shares), JANE STREET GROUP, LLC (17,424 shares), BlackRock Inc. (2,074 shares), and UBS Group AG (1,886 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.